Search hospitals > Georgia > Lawrenceville

Gwinnett Medical Center

Claim this profile
Lawrenceville, Georgia 30045
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
128 reported clinical trials
10 medical researchers
Photo of Gwinnett Medical Center in LawrencevillePhoto of Gwinnett Medical Center in LawrencevillePhoto of Gwinnett Medical Center in Lawrenceville

Summary

Gwinnett Medical Center is a medical facility located in Lawrenceville, Georgia. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Gwinnett Medical Center is involved with conducting 128 clinical trials across 196 conditions. There are 10 research doctors associated with this hospital, such as Rodolfo E. Bordoni, Amelia B Zelnak, MD, Sreekanth C. Reddy, and Gena H. Volas-Redd.

Area of expertise

1Breast Cancer
Global Leader
Gwinnett Medical Center has run 35 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 positive
PR positive
2Cancer
Global Leader
Gwinnett Medical Center has run 33 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at Gwinnett Medical Center

Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Recurrence
ALK Gene Rearrangement
Squamous Cell Carcinoma
Skin Cancer
Cutaneous Melanoma
Lung Adenocarcinoma
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Symptom Monitoring

for Young Women on Hormone Therapy

This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Gwinnett Medical Center?
Gwinnett Medical Center is a medical facility located in Lawrenceville, Georgia. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Gwinnett Medical Center is involved with conducting 128 clinical trials across 196 conditions. There are 10 research doctors associated with this hospital, such as Rodolfo E. Bordoni, Amelia B Zelnak, MD, Sreekanth C. Reddy, and Gena H. Volas-Redd.